Published in Gene Therapy Weekly, December 9th, 2004
According to the announcement, GTI-2040 is currently the subject of a clinical trials agreement with the National Cancer Institute (NCI) under which GTI-2040 is being tested in combination with chemotherapy in five different clinical trials, including studies of GTI 2040 in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.